RPRX financial statements

The full income statement, balance sheet, and cash-flow statement for Royalty Pharma plc (RPRX), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 593.5M2024-09 589.2M2024-12 576.5M2025-03 562.2M2025-06 583.2M2025-09 577.2M2025-12 576.9M2026-03 575.8M2026-06 575.0M-3.1% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeYoYQoQFiguresAs-reported fiscal years.

Line item	FY2025	FY2024	FY2023	FY2022	FY2021
Income Statement	as ofDec 31 ’25	as ofDec 31 ’24	as ofDec 31 ’23	as ofDec 31 ’22	as ofDec 31 ’21
Revenue	2.38B YoY+5.1%	2.26B YoY-3.9%	2.35B YoY+5.2%	2.24B YoY-2.3%	2.29B YoY+7.9%
Research & development	452M YoY+22500.0%	2.00M YoY-96.2%	52.0M YoY-70.6%	177M YoY-11.5%	200M YoY+661.1%
Selling, general & administrative	573M YoY+142.3%	237M YoY-5.2%	250M YoY+9.9%	227M YoY+24.3%	183M YoY+0.6%
General & administrative	573M YoY+142.3%	237M YoY-5.2%	250M YoY+9.9%	227M YoY+24.3%	183M YoY+0.6%
Amortization of intangibles	—	0.00	0.00 YoY-100.0%	5.67M YoY-75.3%	23.0M YoY-0.3%
Provision for credit losses	—	—	—	—	453M YoY+96.2%
Operating income	1.56B YoY+20.7%	1.29B YoY-13.4%	1.49B YoY+385.9%	307M YoY-78.5%	1.43B YoY-10.3%
Interest expense	308M YoY+36.4%	226M YoY+20.5%	187M YoY-0.4%	188M YoY+13.1%	166M YoY+5.8%
Other non-operating income	-14.3M YoY-839.1%	-1.53M YoY+93.0%	-21.7M YoY-47.3%	-14.8M YoY-159.9%	-5.68M YoY+82.7%
Equity-method income	29.1M YoY-1.8%	29.6M YoY+2.5%	28.9M YoY+421.9%	-8.97M YoY+54.0%	-19.5M YoY-143.8%
Gain (loss) on equity securities	-21.9M YoY-155.3%	39.5M YoY-54.6%	87.1M YoY+360.6%	-33.4M YoY+30.4%	-48.1M YoY-119.5%
Pre-tax income	1.32B YoY-0.5%	1.33B YoY-21.7%	1.70B YoY+639.0%	230M YoY-81.5%	1.24B YoY-27.1%
Income tax	0.00	0.00	0.00	0.00	0.00
	771M YoY-10.2%	859M YoY-24.3%	1.13B YoY+2549.5%	42.8M YoY-93.1%	620M YoY-36.4%
Net income to non-controlling interest	553M YoY+17.3%	472M YoY-16.5%	565M YoY+201.9%	187M YoY-69.9%	621M YoY-14.5%
Net income to common	771M YoY-10.2%	859M YoY-24.3%	1.13B YoY+2549.5%	42.8M YoY-93.1%	620M YoY+25.1%
	$1.78 YoY-6.8%	$1.91 YoY-24.5%	$2.53 YoY+2430.0%	$0.10 YoY-93.3%	$1.49 YoY+12.9%
EPS (basic)	$1.79 YoY-6.8%	$1.92 YoY-24.4%	$2.54 YoY+2440.0%	$0.10 YoY-93.3%	$1.49 YoY+12.9%
	430M YoY-4.1%	448M YoY+0.1%	448M YoY+2.2%	438M YoY+5.6%	415M YoY+10.5%
	564M YoY-5.0%	594M YoY-1.5%	603M YoY+37.7%	438M YoY+5.6%	415M YoY+10.5%
Dividends per share	—	$0.84 YoY+5.0%	$0.80 YoY+5.3%	$0.76 YoY+11.8%	$0.68 YoY+126.7%
Balance Sheet	as ofDec 31 ’25	as ofDec 31 ’24	as ofDec 31 ’23	as ofDec 31 ’22	as ofDec 31 ’21
	1.53B YoY-15.2%	1.80B YoY+41.4%	1.27B YoY-50.1%	2.55B YoY-11.2%	2.88B YoY+6.7%
Cash & equivalents	619M YoY-33.4%	929M YoY+94.8%	477M YoY-72.1%	1.71B YoY+11.0%	1.54B YoY+52.8%
Other current assets	6.89M YoY+64.6%	4.19M YoY-76.8%	18.0M YoY-80.1%	90.5M YoY+1265.1%	6.63M YoY-22.9%
	19.6B YoY+7.7%	18.2B YoY+11.2%	16.4B YoY-2.6%	16.8B YoY-4.0%	17.5B YoY+9.3%
Goodwill	925M	0.00	—	—	—
Intangible assets	—	—	—	0.00 YoY-100.0%	5.67M YoY-80.2%
Other non-current assets	79.3M YoY+136.5%	33.5M YoY+414.2%	6.52M YoY-78.0%	29.6M YoY+614.8%	4.14M YoY-58.5%
	636M YoY-49.2%	1.25B YoY+676.8%	161M YoY-86.2%	1.17B YoY+581.3%	171M YoY-44.4%
Accrued liabilities	19.4M YoY+45.1%	13.4M YoY-11.8%	15.2M YoY+91.8%	7.91M YoY+40.7%	5.62M YoY-47.8%
Short-term & current debt	380M YoY-61.9%	998M	0.00 YoY-100.0%	998M	0.00
Other current liabilities	53.2M YoY-22.5%	68.6M YoY+503.1%	11.4M YoY-8.3%	12.4M	0.00 YoY-100.0%
	9.91B YoY+25.7%	7.88B YoY+25.1%	6.30B YoY-13.6%	7.29B YoY+0.3%	7.27B YoY+18.7%
Long-term debt	8.57B YoY+29.6%	6.61B YoY+7.8%	6.14B YoY+0.3%	6.12B YoY-13.8%	7.10B YoY+22.0%
Operating lease liability (total)	19.3M	—	—	—	—
Other non-current liabilities	121M YoY+900.4%	12.1M YoY+1242.2%	900K YoY-64.0%	2.50M	0.00
	9.71B YoY-6.1%	10.3B YoY+2.6%	10.1B YoY+5.9%	9.53B YoY-7.1%	10.2B YoY+3.6%
Additional paid-in capital	4.12B YoY+0.5%	4.10B YoY+2.3%	4.01B YoY+9.4%	3.67B YoY+4.5%	3.51B YoY+22.4%
Retained earnings	2.36B YoY-17.2%	2.85B YoY+13.0%	2.52B YoY+28.1%	1.96B YoY-12.9%	2.26B YoY+17.4%
Treasury stock	2.61M YoY-1.9%	2.66M YoY+1.3%	2.63M YoY-6.3%	2.81M YoY+3.4%	2.71M YoY+17.2%
Accumulated other comprehensive income	—	—	—	0.00 YoY-100.0%	16.5M YoY-52.1%
Non-controlling interest	3.24B YoY-4.6%	3.40B YoY-4.6%	3.56B YoY-8.7%	3.90B YoY-12.9%	4.47B YoY-11.9%
Total equity incl. non-controlling	9.71B YoY-6.1%	10.3B YoY+2.6%	10.1B YoY+5.9%	9.53B YoY-7.1%	10.2B YoY+3.6%
Total liabilities & equity	19.6B YoY+7.7%	18.2B YoY+11.2%	16.4B YoY-2.6%	16.8B YoY-4.0%	17.5B YoY+9.3%
	577M YoY-2.0%	589M YoY-1.4%	597M YoY-1.6%	607M YoY+0.0%	607M YoY+0.0%
Cash Flow	as ofDec 31 ’25	as ofDec 31 ’24	as ofDec 31 ’23	as ofDec 31 ’22	as ofDec 31 ’21
	2.49B YoY-10.1%	2.77B YoY-7.3%	2.99B YoY+39.4%	2.14B YoY+6.3%	2.02B YoY-0.8%
Depreciation & amortization	3.85M	0.00	0.00	—	—
Intangible amortization	—	0.00	0.00 YoY-100.0%	5.67M YoY-75.3%	23.0M YoY-0.3%
Share-based compensation	290M YoY+12267.5%	2.34M YoY-0.6%	2.36M YoY+8.6%	2.17M YoY-11.2%	2.44M YoY-55.0%
	-1.61B YoY+39.7%	-2.68B YoY-29.2%	-2.07B YoY-101.4%	-1.03B YoY+45.0%	-1.87B YoY+32.2%
Acquisitions	74.4M	0.00	0.00	0.00	0.00
Other investing activities	8.95M YoY+538.7%	-2.04M YoY-200.0%	2.04M	0.00	0.00
	-1.19B YoY-428.4%	361M YoY+116.8%	-2.15B YoY-127.4%	-945M YoY-345.3%	385M YoY-74.1%
Long-term debt issued	0.00	0.00	0.00	0.00 YoY-100.0%	1.27B YoY-89.3%
Long-term debt repaid	0.00	0.00	0.00	0.00	0.00 YoY-100.0%
Common stock issued	0.00	0.00	0.00	0.00	0.00
Common stock repurchased	1.23B YoY+434.5%	230M YoY-24.6%	305M	0.00	0.00
Dividends paid	0.00	—	—	—	—
Other financing activities	-1.79M YoY+80.2%	-9.03M	0.00	0.00	—
Net change in cash	-310M YoY-168.7%	452M YoY+136.6%	-1.23B YoY-827.0%	170M YoY-68.1%	532M YoY-30.2%
Interest paid	276M YoY+73.1%	160M YoY-5.7%	169M YoY-0.6%	170M YoY+30.4%	130M YoY+26.4%
Valuation Ratios	as ofDec 31 ’25	as ofDec 31 ’24	as ofDec 31 ’23	as ofDec 31 ’22	as ofDec 31 ’21
Market cap	22.3B YoY+48.4%	15.0B YoY-10.6%	16.8B YoY-30.0%	24.0B YoY-0.8%	24.2B YoY-20.4%
P/E	28.9× YoY+65.3%	17.5× YoY-80.8%	91.2× YoY+92.5%	47.4× YoY+21.3%	39.0× YoY+25.3%
P/S	9.4× YoY+41.2%	6.6× YoY-8.2%	7.2× YoY-32.3%	10.7× YoY+1.0%	10.6× YoY-26.2%
P/B	2.3× YoY+58.0%	1.5× YoY-17.1%	1.8× YoY-23.9%	2.3× YoY-2.4%	2.4× YoY-23.1%
	3.5% YoY-39.5%	5.7% YoY+421.0%	1.1% YoY-48.1%	2.1% YoY-17.5%	2.6% YoY-20.2%
	—	3.3% YoY+15.6%	2.8% YoY+48.1%	1.9% YoY+12.7%	1.7% YoY+184.7%
Source filing	10-K	10-K	10-K	10-K	10-K

About this data

Source: RPRX's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all RPRX filings on SEC EDGAR → Not investment advice.